| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO, Director | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 05 Mar 2026 | 0001106578 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Sale | $1,387,285 | +9,500 | +7308% | $146.03 | 9,630 | 04 Mar 2026 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $194,083 | -399 | -4.1% | $486.42 | 9,231 | 04 Mar 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $451,475 | -926 | -10% | $487.55 | 8,305 | 04 Mar 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $1,186,882 | -2,429 | -29% | $488.63 | 5,876 | 04 Mar 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $1,121,367 | -2,290 | -39% | $489.68 | 3,586 | 04 Mar 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $886,858 | -1,808 | -50% | $490.52 | 1,778 | 04 Mar 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $238,296 | -485 | -27% | $491.33 | 1,293 | 04 Mar 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $119,663 | -243 | -19% | $492.44 | 1,050 | 04 Mar 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $91,279 | -185 | -18% | $493.40 | 865 | 04 Mar 2026 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | $106,369 | -215 | -25% | $494.74 | 650 | 04 Mar 2026 | Direct | F1, F10 |
| transaction | UTHR | Common Stock | Sale | $237,976 | -480 | -74% | $495.78 | 170 | 04 Mar 2026 | Direct | F1, F11 |
| transaction | UTHR | Common Stock | Sale | $19,882 | -40 | -24% | $497.05 | 130 | 04 Mar 2026 | Direct | F1 |
| holding | UTHR | Common Stock | 166 | 04 Mar 2026 | by Spouse | ||||||
| holding | UTHR | Common Stock | 324,518 | 04 Mar 2026 | by Trust | F12 | |||||
| holding | UTHR | Common Stock | 258,117 | 04 Mar 2026 | by Trust | F13 | |||||
| holding | UTHR | Common Stock | 45,596 | 04 Mar 2026 | by Trust | F14 | |||||
| holding | UTHR | Common Stock | 10,962 | 04 Mar 2026 | by Trust | F15 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Options | Options Exercise | -9,500 | -4.3% | $0.000000* | 211,500 | 04 Mar 2026 | Common Stock | 9,500 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. |
| F10 | This transaction was executed in multiple trades at prices ranging from $494.28 to $495.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F11 | This transaction was executed in multiple trades at prices ranging from $495.39 to $496.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F12 | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F13 | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F14 | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F15 | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F2 | This transaction was executed in multiple trades at prices ranging from $486.01 to $486.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $487.05 to $488.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $488.07 to $489.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $489.08 to $490.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $490.08 to $491.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $491.10 to $492.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $492.12 to $492.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $493.23 to $493.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |